Allogeneic Marrow Transplantation

Overview

Journal Cancer Invest

Specialty Oncology

Date 1984 Jan 1

PMID 6367899

Citations 5

Authors

K M Sullivan

R Storb

Affiliations

Soon will be listed here.

Abstract

After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.

Citing Articles

Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies.

Zahid M, Ali N, Shaikh M, Adil S Int J Hematol Oncol Stem Cell Res. 2015; 8(4):30-8.

PMID: 25774265 PMC: 4345295.

Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center.

Price K, Cardenas-Turanzas M, Lin H, Roden L, Nigam R, Nates J Minerva Anestesiol. 2012; 79(2):147-55.

PMID: 23032926 PMC: 3935771.

Outcome and prognostic indicators of patients with hematopoietic stem cell transplants admitted to the intensive care unit.

Huynh T, Weigt S, Belperio J, Territo M, Keane M J Transplant. 2010; 2009:917294.

PMID: 20130763 PMC: 2809022. DOI: 10.1155/2009/917294.

Laminar air flow isolation and decontamination: a prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients.

Petersen F, Buckner C, Clift R, Lee S, Nelson N, COUNTS G Infection. 1986; 14(3):115-21.

PMID: 3089939 DOI: 10.1007/BF01643474.

The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study.

Petersen F, Thornquist M, Buckner C, Counts G, Nelson N, Meyers J Infection. 1988; 16(4):199-208.

PMID: 3053457 DOI: 10.1007/BF01650752.